The Lundquist Institute Appoints Joe W. Ramos, PhD, as New President and Chief Executive Officer
08. Januar 2025 14:00 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is pleased to announce the appointment of Joe W. Ramos,...
TLI Investigators William Stringer MD and Asghar Abbasi PhD, along with Ke Zhang MD of Allerdia Inc., receive $2 Million NIH/NHLBI Grant to Develop Novel Point-of-Care Test for Allergic Asthma Detection
06. November 2024 11:00 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is proud to announce the receipt of a $2 million grant from...
The Lundquist Institute and Mayo Clinic Awarded $2.46M NIH Grant to Investigate Cellular Senescence in Trisomy 21 Lung Disease
21. Oktober 2024 15:09 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with Mayo Clinic, is proud to announce...
The Lundquist Institute Announces Updates to Its Board of Directors
26. August 2024 15:39 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) announced updates to its Board of Directors today. TLI...
The Lundquist Institute WIC Program Receives USDA 2024 WIC Breastfeeding Gold Award of Excellence
14. August 2024 15:00 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is pleased to announce that its WIC Program has received...
Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndrome
21. Juni 2024 08:00 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, June 21, 2024 (GLOBE NEWSWIRE) -- As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including...
TLI Investigator Dr. Marianne Gausche-Hill Co-authors New Study Revealing Cost-Effectiveness of Pediatric Readiness in Emergency Departments
11. Juni 2024 10:34 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, June 11, 2024 (GLOBE NEWSWIRE) -- A groundbreaking study published in the Journal of the American College of Emergency Physicians Open demonstrates that adhering to national...
Lundquist Investigator Dr. Ashraf Ibrahim Is the Lead Author in the Landmark Study on Pioneering Oral Fungal Infection Treatment Showing Promise in Preclinical Trials
30. April 2024 08:00 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, April 30, 2024 (GLOBE NEWSWIRE) -- A novel oral amphotericin B (MAT2203) developed by Matinas BioPharma for treatment of invasive mucormycosis (IM) and other deadly invasive...
The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition Activity to Develop Wearable Biosensors
24. April 2024 20:32 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, April 24, 2024 (GLOBE NEWSWIRE) -- The U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded The Lundquist Institute (TLI) a four-year grant totaling...
Lundquist Investigator Dr. Yoshihara Awarded $3 Million NIH R01 Grant for Diabetes Stem Cell Therapy Research
01. April 2024 17:52 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, April 01, 2024 (GLOBE NEWSWIRE) -- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health, has granted...